Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 24 | 354,405 | $44.78M |
| Grant or award | 2 | 19,912 | |
| Option exercise | 26 | 644,244 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
120 Form 4 filings on record, the earliest from Dec 13, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Common Stock | 5,000 | $127.53 | $638K | ||
| Option exercise | Common Stock | 82,280 | $13.67 | $1.12M | ||
| Option exercise | Common Stock | 76,600 | $17.16 | $1.31M | ||
| Option exercise | Common Stock | 80,970 | $30.46 | $2.47M | ||
| Open-market sale | Common Stock | 239,850 | $133.27 | $31.96M | ||
| Option exercise | Stock Option (right to buy) | 82,280 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 76,600 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 80,970 | $0.00 | - | ||
| Martina M.D. Flammer - Officer | Option exercise | Common Stock | 18,278 | $18.95 | $346K | |
| Martina M.D. Flammer - Officer | Option exercise | Common Stock | 8,895 | $25.83 | $230K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 8,895 | $127.00 | $1.13M | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 18,278 | $129.40 | $2.37M | |
| Martina M.D. Flammer - Officer | Option exercise | Stock Option (right to buy) | 18,278 | $0.00 | - | |
| Martina M.D. Flammer - Officer | Option exercise | Stock Option (right to buy) | 8,895 | $0.00 | - | |
| Option exercise | Common Stock | 6,260 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 4,828 | $105.62 | $510K | ||
| Open-market sale | Common Stock | 5,872 | $106.43 | $625K | ||
| Option exercise | Stock Option (right to buy) | 6,260 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 5,005 | $116.55 | $583K | ||
| Open-market sale | Common Stock | 2,335 | $117.62 | $275K | ||
| Open-market sale | Common Stock | 3,359 | $118.52 | $398K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Martina M.D. Flammer - Officer | Option exercise | Common Stock | 7,945 | $29.13 | $231K | |
| Martina M.D. Flammer - Officer | Option exercise | Common Stock | 4,357 | $19.74 | $86K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 4,854 | $109.02 | $529K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 7,448 | $110.60 | $824K | |
| Martina M.D. Flammer - Officer | Option exercise | Stock Option (right to buy) | 7,945 | $0.00 | - | |
| Martina M.D. Flammer - Officer | Option exercise | Stock Option (right to buy) | 4,357 | $0.00 | - | |
| Open-market sale | Common Stock | 3,723 | $104.28 | $388K | ||
| Open-market sale | Common Stock | 2,456 | $105.27 | $259K | ||
| Open-market sale | Common Stock | 1,292 | $106.27 | $137K | ||
| Option exercise | Stock Option (right to buy) | 12,518 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 8,880 | $0.00 | - | ||
| Option exercise | Common Stock | 12,518 | $30.46 | $381K | ||
| Option exercise | Common Stock | 8,880 | $17.16 | $152K | ||
| Open-market sale | Common Stock | 12,091 | $102.34 | $1.24M | ||
| Open-market sale | Common Stock | 1,836 | $103.10 | $189K | ||
| Samuele Butera - Officer | Grant or award | Common Stock | 7,342 | - | - | |
| Samuele Butera - Officer | Grant or award | Stock Option (right to buy) | 12,570 | $0.00 | - | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 1,806 | $95.82 | $173K | |
| Open-market sale | Common Stock | 6,515 | $94.03 | $613K | ||
| Open-market sale | Common Stock | 2,370 | $102.27 | $242K | ||
| Sara Bonstein - Officer | Open-market sale | Common Stock | 2,404 | $102.27 | $246K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 2,159 | $102.27 | $221K | |
| Open-market sale | Common Stock | 7,605 | $102.27 | $778K | ||
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 2,566 | $102.27 | $262K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 1,858 | $103.78 | $193K | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 6,149 | $108.47 | $667K | |
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Open-market sale | Common Stock | 5,753 | $105.32 | $606K | ||
| Open-market sale | Common Stock | 11,836 | $106.39 | $1.26M | ||
| Open-market sale | Common Stock | 7,975 | $106.97 | $853K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - | ||
| Sara Bonstein - Officer | Open-market sale | Common Stock | 8,272 | $116.18 | $961K | |
| Carol Schafer - Director | Grant or award | Common Stock | 3,305 | - | - | |
| Open-market sale | Common Stock | 5,837 | $116.18 | $678K | ||
| Elizabeth M. Anderson - Director | Grant or award | Common Stock | 3,305 | - | - | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 4,470 | $112.76 | $504K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 3,384 | $116.18 | $393K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 10,479 | $117.54 | $1.23M | |
| Michael Alexander Smith - Officer | Open-market sale | Common Stock | 4,109 | $116.18 | $477K | |
| Grant or award | Common Stock | 3,305 | - | - | ||
| David R. Brennan - Director | Grant or award | Common Stock | 3,305 | - | - | |
| Clarissa Desjardins - Director | Grant or award | Common Stock | 3,305 | - | - | |
| Leo Lee - Director | Grant or award | Common Stock | 3,305 | - | - | |
| Open-market sale | Common Stock | 13,283 | $116.18 | $1.54M | ||
| Martina M.D. Flammer - Officer | Option exercise | Common Stock | 12,949 | $17.07 | $221K | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 12,119 | $100.35 | $1.22M | |
| Martina M.D. Flammer - Officer | Open-market sale | Common Stock | 830 | $101.18 | $84K | |
| Martina M.D. Flammer - Officer | Option exercise | Stock Option (right to buy) | 12,949 | $0.00 | - | |
| Open-market sale | Common Stock | 433 | $134.18 | $58K | ||
| Open-market sale | Common Stock | 599 | $135.18 | $81K | ||
| Open-market sale | Common Stock | 5,318 | $137.01 | $729K | ||
| Open-market sale | Common Stock | 2,721 | $137.86 | $375K | ||
| Open-market sale | Common Stock | 1,247 | $139.09 | $173K | ||
| Open-market sale | Common Stock | 381 | $139.60 | $53K | ||
| Option exercise | Common Stock | 6,259 | $30.46 | $191K | ||
| Option exercise | Common Stock | 4,440 | $17.16 | $76K | ||
| Option exercise | Stock Option (right to buy) | 6,259 | $0.00 | - | ||
| Option exercise | Stock Option (right to buy) | 4,440 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MELVIN SHAROKY | Director | 5,000 | $638K | View on EDGAR | |
| Roger Adsett | Officer | 239,850 | $31.96M | View on EDGAR | |
| Martina Flammer | Officer | 27,173 | $3.49M | View on EDGAR |
INSMED Inc (INSM) had 15 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for INSM runs to 120 Form 4 filings, the earliest from 2024-12-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of INSM were filed in the last 90 days. 2 purchases are on record for this company.
24 insider sales of INSM were filed in the last 90 days, totaling $44.78M.
This page tracks INSM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add INSM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.